"This is all about continuation of care, assuring patients don't experience some interruption of therapy," Brunner said
Treatment Categories for IC/BPS The Panel assessed the available data for each treatment to determine whether a specific intervention demonstrated sufficient efficacy to be included as a treatment alternative
Linnebjerg H, Kothare PA, Park S, Mace K, Reddy S, Mitchell M, et al
The clinical evidence is unambiguous
Key Takeaways GLP-1 receptor agonists have evolved from diabetes medications into essential cardiovascular drugs, offering proven protection against heart attacks, strokes, and cardiovascular death across diverse patient populations
PlexusDx compounded semaglutide ($189/mo) and oral semaglutide ($289/mo month-to-month, or from $249/mo on the 6-month plan) provide affordable treatment options while you work with your provider on a discontinuation timeline that accounts for your unique metabolic needs